Yahoo Finance Does Emerson Electric Co.'s (NYSE:EMR) 30% Earnings Growth Make It An Outperformer?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!
For investors, increase in profitability and industry-beating performance can be essential considerations in an investment. Below, I will examine Emerson Electric Co.'s (NYSE:EMR) track record on a high level, to give you some insight into how the company has been performing against its long term trend and its industry peers.
Check out our latest analysis for Emerson Electric
Commentary On EMR's Past Performance
EMR's trailing twelve-month earnings (from 31 March 2019) of US$2.3b has jumped 30% compared to the previous year.
Furthermore, this one-year growth rate has exceeded its 5-year annual growth average of -3.8%, indicating the rate at which EMR is growing has accelerated. What's enabled this growth? Let's take a look at whether it is solely due to an industry uplift, or if Emerson Electric has seen some company-specific growth.
In terms of returns from investment, Emerson Electric has invested its equity funds well leading to a 27% return on equity (ROE), above the sensible minimum of 20%. Furthermore, its return on assets (ROA) of 12% exceeds the US Electrical industry of 7.8%, indicating Emerson Electric has used its assets more efficiently. And finally, its return on capital (ROC), which also accounts for Emerson Electric’s debt level, has increased over the past 3 years from 19% to 21%.
What does this mean?
Emerson Electric's track record can be a valuable insight into its earnings performance, but it certainly doesn't tell the whole story. Companies that have performed well in the past, such as Emerson Electric gives investors conviction. However, the next step would be to assess whether the future looks as optimistic. You should continue to research Emerson Electric to get a more holistic view of the stock by looking at:
Future Outlook: What are well-informed industry analysts predicting for EMR’s future growth? Take a look at our free research report of analyst consensus for EMR’s outlook.
Financial Health: Are EMR’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
NB: Figures in this article are calculated using data from the trailing twelve months from 31 March 2019. This may not be consistent with full year annual report figures.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.
